Literature DB >> 2138424

Hypertensive-diabetic cardiomyopathy in rats.

F S Fein1, B E Zola, A Malhotra, S Cho, S M Factor, J Scheuer, E H Sonnenblick.   

Abstract

Left ventricular papillary muscle function, transmembrane action potentials, myosin adenosinetriphosphatase (ATPase) and isoenzyme distribution, and myocardial pathology were studied in hypertensive (H), diabetic (D), hypertensive-diabetic (HD), and control (C) rats. There was approximately 50% relative left ventricular hypertrophy in H and HD rats. Relative lung and liver weights were greater in HD rats. Peak velocity of shortening tended to decrease progressively in H, D, and HD rats. The duration of contraction and relaxation was markedly prolonged in Ds and HDs. The length-developed tension relation was blunted in HDs. The negative inotropic effect of verapamil was similar in all groups. Resting membrane potential and amplitude were decreased in D and HD rats. Action potential duration was increased in H, D, and especially HD rats. The shortening of action potential duration with increased stimulus frequency was greater in H, D, and especially HD rats than in Cs. Left ventricular myosin ATPase and V1 isoenzyme content decreased progressively in H, D, and HD rats. Right ventricular V1 isoenzyme content was not affected in H rats but was markedly decreased in D and HD rats. Left (and right) ventricular pathology was unchanged in rats with diabetes but was increased in rats with hypertension. These data suggest that the combination of myocardial pathology (due to hypertension) and cellular dysfunction (caused mainly by diabetes) may result in cardiomyopathy and congestive heart failure in the HD rat.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2138424     DOI: 10.1152/ajpheart.1990.258.3.H793

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

1.  Anatomical and functional cardiac abnormalities in type I diabetes.

Authors:  F Illan; M Valdés-Chávarri; J Tebar; A García; H Pascual; F Soria; A Hernández; T Vicente
Journal:  Clin Investig       Date:  1992-05

2.  Aminoguanidine ameliorates albuminuria in diabetic hypertensive rats.

Authors:  D Edelstein; M Brownlee
Journal:  Diabetologia       Date:  1992-01       Impact factor: 10.122

Review 3.  Diabetic cardiomyopathy.

Authors:  F S Fein; E H Sonnenblick
Journal:  Cardiovasc Drugs Ther       Date:  1994-02       Impact factor: 3.727

4.  Tension cost correlates with mechanical and biochemical parameters in different myocardial contractility conditions.

Authors:  Cleci M Moreira; Eduardo F Meira; Luis Vestena; Ivanita Stefanon; Dalton V Vassallo; Alessandra S Padilha
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

5.  Hypertension is a conditional factor for the development of cardiac hypertrophy in type 2 diabetic mice.

Authors:  Marc van Bilsen; Anneleen Daniels; Olaf Brouwers; Ben J A Janssen; Wouter J A Derks; Agnieszka E Brouns; Chantal Munts; Casper G Schalkwijk; Ger J van der Vusse; Frans A van Nieuwenhoven
Journal:  PLoS One       Date:  2014-01-09       Impact factor: 3.240

Review 6.  Electrical Features of the Diabetic Myocardium. Arrhythmic and Cardiovascular Safety Considerations in Diabetes.

Authors:  Mónica Gallego; Julián Zayas-Arrabal; Amaia Alquiza; Beatriz Apellaniz; Oscar Casis
Journal:  Front Pharmacol       Date:  2021-07-08       Impact factor: 5.810

7.  Diabetes mellitus activates fetal gene program and intensifies cardiac remodeling and oxidative stress in aged spontaneously hypertensive rats.

Authors:  Camila Moreno Rosa; Natasha Priscilla Xavier; Dijon Henrique Campos; Ana Angélica Henrique Fernandes; Marcelo Diarcadia Mariano Cezar; Paula Felippe Martinez; Antonio Carlos Cicogna; Camila Gimenes; Rodrigo Gimenes; Marina Politi Okoshi; Katashi Okoshi
Journal:  Cardiovasc Diabetol       Date:  2013-10-17       Impact factor: 9.951

8.  Association of patient-reported outcomes and heart rate trends in heart failure: a report from the Chiron project.

Authors:  Luca Monzo; Michele Schiariti; Pietro Fedele Calvisi; Silvio Bonfiglio; Mitja Luštrek; Paolo E Puddu
Journal:  Sci Rep       Date:  2020-01-17       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.